These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. Metin O; Yazici K; Tot S; Yazici AE Hum Psychopharmacol; 2003 Aug; 18(6):463-7. PubMed ID: 12923825 [TBL] [Abstract][Full Text] [Related]
28. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders]. Nakamae T Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889 [TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012. Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958 [TBL] [Abstract][Full Text] [Related]
31. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
32. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases. Sun TF; Lin PY; Wu CK Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630 [TBL] [Abstract][Full Text] [Related]
33. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder]. Vloet TD; Simons M; Herpertz-Dahlmann B Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940 [TBL] [Abstract][Full Text] [Related]